grant

Personalizing Antimicrobial Use in Ventilator-Associated Pneumonia

Organization UNIVERSITY OF MICHIGAN AT ANN ARBORLocation ANN ARBOR, UNITED STATESPosted 18 Jun 2024Deadline 31 May 2029
NIHUS FederalResearch GrantFY2025AcademyAddressAdverse drug eventAffectAlveolarAntibiotic AgentsAntibiotic DrugsAntibiotic TherapyAntibiotic TreatmentAntibioticsAssayAwardBioassayBiologicalBiological AssayBiological MarkersBiometricsBiometryBiostatisticsBronchioalveolar LavageBronchoalveolar LavageBronchoalveolar Lavage FluidBronchopulmonary LavageCareer MobilityCaringCase StudyClinicalClinical InvestigatorClinical TrialsCohort StudiesColimycinColisticinColistinCollectionCombined Modality TherapyCommunicable DiseasesComplexConcurrent StudiesConsensusCoupledCritical IllnessCritically IllDataData ScienceDecision AnalysisDecision MakingDedicationsDevelopment PlansDiagnosisDrug resistanceDysfunctionEnsureEpidemiologyFaceFunctional disorderFundingFutureGoalsGuidelinesHealthHealth Care CostsHealth CostsHospital AdmissionHospital InfectionsHospital acquired infectionHospitalizationInfectionInfectious DiseasesInfectious DisorderInternal MedicineLungLung LavageLung Respiratory SystemMDR organismMDR pathogenManuscriptsMapsMarket ResearchMeasuresMediatingMentorsMethodologyMichiganMiscellaneous AntibioticModelingMorbidityMorbidity - disease rateMultimodal TherapyMultimodal TreatmentNeutrophiliaNosocomial InfectionsNosocomial pneumoniaNucleic Acid Amplification TestsNucleic Acid TestingOrganOutcomePatient outcomePatient-Centered OutcomesPatient-Focused OutcomesPatientsPeer ReviewPerformancePharmaceutical AgentPharmaceuticalsPharmacologic SubstancePharmacological SubstancePhysiopathologyPneumoniaPolymyxin EPositionPositioning AttributeProfessional OrganizationsPublicationsRecommendationRecurrenceRecurrentResearchRiskSafetyScientific PublicationSepsisSeriesSiteSurvey InstrumentSurvey MethodSurvey MethodologySurveysSyndromeTechniquesTestingTrainingTreatment FailureTreatment PeriodUniversitiesWorkanti-microbialantimicrobialbacterial disease treatmentbacterial infectious disease treatmentbio-markersbiologicbiologic markerbiomarkerbiomarker signaturebronchiolar alveolar lavagebronchopulmonary lavage therapycareercareer advancementcareer developmentcareer transitioncase reportclinical epidemiologyclinical translationclinically translatablecombination therapycombined modality treatmentcombined treatmentcostdrug resistantepidemiologicepidemiologicalextensive drug resistanceextensively drug resistantextreme drug resistancefacesfacialhealthcare-associated pneumoniahospital acquired pneumoniahospital associated pneumoniaimprovedinnovateinnovationinnovativeinstitutional infectionmortalitymulti-drug resistant organismmulti-drug resistant pathogenmulti-modal therapymulti-modal treatmentmultidrug resistant organismmultidrug resistant pathogenmultiple drug resistant organismmultiple drug resistant pathogennovelover-treatmentovertreatmentpathogenpathophysiologypatient oriented outcomespharmaceuticalpneumonia therapypneumonia treatmentpredictive biological markerpredictive biomarkerspredictive markerpredictive molecular biomarkerpreferenceprofessional associationprofessional membershipprofessional societyprofessorprospectiveresistance to Drugresistant to Drugrespiratoryresponse to therapyresponse to treatmentsecondary analysisside effectspecific biomarkersstandard of caretherapeutic responsetherapy failuretherapy responsetooltreat pneumoniatreatment daystreatment durationtreatment effecttreatment responsetreatment responsivenesstrendtrial designventilator-acquired pneumoniaventilator-associated pneumonia
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

Candidate’s Long-Term Career Goals: To become an independent clinical investigator that strengthens ICU
antimicrobial stewardship and personalizes antibiotic use in nosocomial pneumonia.

Clinical Problems to be Addressed with this project: Ventilator-associated pneumonia (VAP) is common,

costly, and a leading cause of morbidity and mortality in…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
Personalizing Antimicrobial Use in Ventilator-Associated Pneumonia — UNIVERSITY OF MICHIGAN AT ANN ARBOR | UNITED STATES | Dev Procure